Clinical Trials Browser

OTHER × Standard of Care × Genitourinary × Clear all

NCT04396808 2026-04-15

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

Phase NA Active not recruiting

Prostatic Neoplasms

NCT05487846 2026-04-14

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Phase NA Recruiting

Prostatic Neoplasms

NCT07524426 2026-04-13

LORUP

Phase NA Not yet recruiting

Urinary Bladder Neoplasms

NCT07126548 2026-04-06

A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07512076 2026-04-06

A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06401980 2026-03-30

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT04905082 2026-03-24

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

Phase NA Active not recruiting

465 enrolled 11 charts

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06391099 2026-03-19

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Phase NA Recruiting

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT06422455 2026-03-18

Access to Genetic Testing in Underserved Patients With Cancer

Phase NA Recruiting

BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT07302230 2026-03-13

EMPOWER

Phase NA Recruiting

Urinary Bladder Neoplasms

NCT06528990 2026-03-05

Telehealth Intervention for Ostomy Self-Management

Phase 2 Recruiting

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Colorectal Neoplasms

NCT06040762 2026-03-02

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Phase NA Recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06037863 2026-02-23

Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

Phase NA Active not recruiting

Prostatic Neoplasms

NCT04731376 2026-02-11

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Phase 1 Active not recruiting

Hypogonadism, Urologic Diseases, Urologic Neoplasms

NCT06563388 2026-02-04

ID-COMET

Phase 3 Recruiting

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT07218718 2026-01-28

Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy

Phase NA Recruiting

Prostatic Neoplasms

NCT06296147 2026-01-16

Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

Phase NA Recruiting

Prostatic Neoplasms

NCT04870515 2026-01-09

Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study

Phase NA Completed

20 enrolled 12 charts

Localized Prostate Carcinoma

NCT03151629 2026-01-06

IRONMAN

Prostatic Neoplasms

NCT05519878 2025-12-24

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Phase NA Recruiting

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT07087860 2025-12-09

RECIPE-B1

Phase 2 Recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT03511196 2025-12-04

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms

NCT06046131 2025-11-17

KP-CARAIBES

Phase NA Recruiting

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT05454488 2025-11-14

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT03734653 2025-11-06

Testosterone Therapy in Castration Resistant Prostate Cancer

Phase EARLY_PHASE1 Completed

Prostatic Neoplasms

NCT06014255 2025-10-29

HEAT

Phase 2 Recruiting

Prostatic Neoplasms

NCT04751435 2025-10-21

IMAGINE

Phase NA Recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT05754658 2025-10-06

African Cancer Genome: GMD

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT03075423 2025-09-26

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

Phase 2 Completed

Carcinoma, Renal Cell

NCT04763915 2025-09-19

IMPACT

Phase NA Active not recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07135271 2025-08-22

BeSpoke

Phase NA Not yet recruiting

Localised Prostate Cancer

NCT07126860 2025-08-17

ZMoveMent-1

Phase NA Recruiting

Psychological Well-Being, Motor Activity, Prostatic Neoplasms

NCT07053462 2025-07-08

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Phase 1/2 Recruiting

Carcinoma, Renal Cell, Kidney Failure, Chronic, Renal Insufficiency

NCT06903312 2025-07-03

ITALIC-RCC

Phase 4 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04115007 2025-06-26

Oligo-PRESTO

Phase 3 Active not recruiting

Oligometastatic Hormone Sensitive Prostate Cancer

NCT06625970 2025-06-26

PEACE 7

Phase 3 Recruiting

Prostatic Neoplasms

NCT03582774 2025-05-13

PSMA SRT

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT03763253 2025-02-07

IP2-ATLANTA

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT03103321 2025-01-27

Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

Phase 3 Completed

158 enrolled 13 charts

Prostatic Neoplasms

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Phase NA Completed

128 enrolled 24 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT06496581 2024-12-20

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

Phase 3 Recruiting

Genital Diseases, Male, Prostatic Diseases

NCT02220829 2024-12-09

Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Phase 3 Completed

Prostatic Neoplasms

NCT05905276 2024-10-04

Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT

Phase NA Completed

Urinary Bladder Neoplasms

NCT03017417 2024-07-18

COMRADE

Phase NA Completed

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT04295447 2024-06-20

ADAM

Phase 2 Active not recruiting

Neoplasms, Prostatic Neoplasms

NCT04694924 2024-05-22

Prosquare

Prostatic Neoplasms

NCT04496219 2024-01-02

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Phase 2 Completed

45 enrolled 16 charts

Urinary Bladder Neoplasms

NCT03390595 2023-10-18

INDUCOMAIN

Phase 2 Completed

Carcinoma, Transitional Cell

NCT00769652 2023-10-03

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

Phase NA Terminated

8 enrolled 6 charts

GastrointestinalGenitourinaryThoracic

Body Weight Changes, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Malnutrition, Small Cell Lung Carcinoma

NCT02957981 2023-09-13

GEM

Phase NA Completed

BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Multiple Endocrine Neoplasia Type 1